ZEALAND PHARMA A S's ticker is ZEAL and the CUSIP is 98920Y304. A total of 11 filers reported holding ZEALAND PHARMA A S in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $476,000 | +27.6% | 22,108 | +0.9% | 0.00% | 0.0% |
| Q1 2019 | $373,000 | +46.9% | 21,903 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $254,000 | -34.5% | 21,903 | -6.8% | 0.00% | 0.0% |
| Q3 2018 | $388,000 | +28.1% | 23,503 | -1.5% | 0.00% | 0.0% |
| Q2 2018 | $303,000 | -17.7% | 23,868 | -2.6% | 0.00% | 0.0% |
| Q1 2018 | $368,000 | +10.5% | 24,500 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $333,000 | -29.1% | 24,500 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $470,000 | – | 24,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT LLC | 750,000 | $25,875,000 | 0.22% |
| AWM Investment Company, Inc. | 19,981 | $689,000 | 0.18% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 5,653 | $183,000 | 0.08% |
| OLD MISSION CAPITAL LLC | 15,890 | $548,000 | 0.05% |
| WELLINGTON MANAGEMENT GROUP LLP | 1,433,091 | $49,442,000 | 0.01% |
| ROYCE & ASSOCIATES LP | 10,000 | $345,000 | 0.01% |
| STATE OF WISCONSIN INVESTMENT BOARD | 44,092 | $1,521,000 | 0.01% |
| Rockefeller Capital Management L.P. | 8,876 | $306,000 | 0.00% |
| Winslow, Evans & Crocker, Inc. | 236 | $10,000 | 0.00% |
| Filbrandt Wealth Management, LLC | 25 | $1,000 | 0.00% |